Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

740 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease.
Nagasawa R, Hara Y, Murohashi K, Aoki A, Kobayashi N, Takagi S, Hashimoto S, Kawana A, Kaneko T. Nagasawa R, et al. Among authors: aoki a. BMC Pulm Med. 2020 Nov 25;20(1):310. doi: 10.1186/s12890-020-01341-1. BMC Pulm Med. 2020. PMID: 33238962 Free PMC article.
The Extent of Honeycombing on Computed Tomography Cannot Predict the Treatment Outcome of Patients with Acute Exacerbations of Interstitial Lung Disease.
Nishikawa Y, Hara Y, Tagami Y, Nagasawa R, Murohashi K, Aoki A, Tanaka K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T. Nishikawa Y, et al. Among authors: aoki a. Can Respir J. 2021 Nov 16;2021:7456315. doi: 10.1155/2021/7456315. eCollection 2021. Can Respir J. 2021. PMID: 34824651 Free PMC article.
Comparison of Clinical Features between the High and Low Serum KL-6 Patients with Acute Exacerbation of Interstitial Lung Diseases.
Tagami Y, Hara Y, Murohashi K, Nagasawa R, Nishikawa Y, Tanaka M, Aoki A, Tanaka K, Nakashima K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Okudela K, Kaneko T. Tagami Y, et al. Among authors: aoki a. Can Respir J. 2021 Nov 30;2021:9099802. doi: 10.1155/2021/9099802. eCollection 2021. Can Respir J. 2021. PMID: 34887972 Free PMC article.
Diffuse alveolar hemorrhage complicating acute exacerbation of IPF.
Murohashi K, Hara Y, Aoki A, Matsumura M, Kataoka T, Okudela K, Kaneko T. Murohashi K, et al. Among authors: aoki a. Respir Med Case Rep. 2020 Feb 7;29:101022. doi: 10.1016/j.rmcr.2020.101022. eCollection 2020. Respir Med Case Rep. 2020. PMID: 32071858 Free PMC article.
Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019.
Hara Y, Oshima Y, Tagami Y, Aoki A, Fujii H, Izawa A, Seki K, Kanai A, Yabe A, Watanabe K, Horita N, Kobayashi N, Kaneko T. Hara Y, et al. Among authors: aoki a. Respir Med Case Rep. 2022;36:101615. doi: 10.1016/j.rmcr.2022.101615. Epub 2022 Feb 20. Respir Med Case Rep. 2022. PMID: 35223424 Free PMC article.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kobayashi N, et al. Among authors: aoki a. Thorac Cancer. 2020 Aug;11(8):2125-2129. doi: 10.1111/1759-7714.13503. Epub 2020 Jun 3. Thorac Cancer. 2020. PMID: 32495514 Free PMC article. Clinical Trial.
740 results